Diabetes genetic predisposition score and cardiovascular complications among patientswith type 2 diabetes

Diabetes Care

Volumn 36, Issue 3, 2013, Pages 737-739

  Qi, Qibin ^a   Meigs, James B ^b   Rexrode, Kathryn M ^c   Hu, Frank B ^a,c   Qi, Lu ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC PREDISPOSITION SCORE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 84874444712     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0852     Document Type: Article

References (15)

1. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995;44:369-"374
2. Pfister R, Barnes D, Luben RN, Khaw KT, Wareham NJ, Langenberg C. Individual and cumulative effect of type 2 diabetes genetic susceptibility variants on risk of coronary heart disease. Diabetologia 2011; 54:2283-"2287
3. ColditzGA, Manson JE,Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 1997;6:49-"62
4. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464-"468
5. Qi L, Cornelis MC, Kraft P, et al.; Meta-Analysis of Glucose and Insulin-related traits Consortium (MAGIC); Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet 2010;19: 2706-"2715
6. Qi Q, Workalemahu T, Zhang C, Hu FB, Qi L. Genetic variants, plasma lipoprotein (a) levels, and risk of cardiovascular morbidity andmortality among two prospective cohorts of type 2 diabetes. Eur Heart J 2012; 33:325-"334
7. He M, CornelisMC, Franks PW, Zhang C, Hu FB, Qi L. Obesity genotype score and cardiovascular risk in women with type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2010;30:327-"332
8. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010;363: 2339-"2350
9. Grarup N, Sparsø T, Hansen T. Physiologic characterization of type 2 diabetes-related loci. Curr Diab Rep 2010;10:485-"497
10. Qi Q, Li H, Wu Y, et al. Combined effects of 17 common genetic variants on type 2 diabetes risk in aHan Chinese population. Diabetologia 2010;53:2163-"2166
11. AshokKumar M, Veera Subhashini NG, Kanthimathi S, et al. Associations for lipoprotein lipase and peroxisome proliferatoractivated receptor-g gene and coronary artery disease in an Indian population. Arch Med Res 2010;41:19-"25.e1
12. Bielinski SJ, Pankow JS, Folsom AR, North KE, Boerwinkle E. TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2008;51:968-"970
13. Dallongeville J, Iribarren C, Ferrières J, et al. Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease. PPAR Res 2009;2009: 543746
14. Ridker PM, Cook NR,Cheng S, et al. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol 2003;23:859-"863
15. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-"2581